Skip to content

Treatment for Patellofemoral Pain Syndrome Using Footwear

Treatment for Patellofemoral Pain Syndrome Using Knee Abduction Moment-Reducing Footwear

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01332110
Enrollment
36
Registered
2011-04-08
Start date
2011-06-30
Completion date
2012-08-31
Last updated
2014-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral Pain Syndrome

Keywords

Footwear, Motion Analysis, Running Injury

Brief summary

Patellofemoral pain syndrome (PFPS) is the most common running injury and is believed to be associated with higher than normal knee joint loading. Footwear has been developed that may decrease these knee loads in healthy subjects, but their effects on patients with PFPS are unknown. In this study, we aim to test the effects of such footwear on patients with PFPS. We hypothesize that patients who receive the footwear intervention will show a decrease in knee joint loading, and consequently will show improvements in subjective levels of perceived knee pain over a period of six weeks compared to a control condition.

Interventions

DEVICEKnee abduction moment-reducing footwear

Patients in each study group will be asked to run using their assigned footwear at least 3 times per week (minimum 15 km per week) for six weeks. Each patient will document their perceived knee pain each week throughout the six week intervention.

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
University of Calgary
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Male or Female between 18 and 45 years of age. * Have been diagnosed with patellofemoral pain syndrome (PFPS) by a physician. * Have nontraumatic unilateral and/or bilateral peripatellar or retropatellar knee pain. * Patellofemoral knee pain with and/or after activity. * Inactivity patellofemoral pain and/or stiffness, especially with sitting with knees held in flexed posture. * Peripatellar tenderness ± mild inferior patellar pole tenderness. * Run at least 15km per week. * Are heel-toe runners (as opposed to forefoot strikers).

Exclusion criteria

* Are currently, or have previously, participated in any other forms of treatment for their knee pain. * Significant articular or periarticular effusion or bursitis. * Significant joint line tenderness. * Intra-articular ligamentous instability. * Patellar apprehension. * Have undergone any form of knee surgery or arthroscopy. * Have any other neuromuscular, musculoskeletal or cardiovascular conditions

Design outcomes

Primary

MeasureTime frameDescription
Knee joint internal abduction moments of force during running at 4m/sFirst day of joining the studyMotion analysis trials will be conducted on each subject with both the control and intervention footwear. Inverse dynamics calculations will reveal the internal joint loading for each subject. Knee joint moments will be compared within subjects for each footwear condition.

Secondary

MeasureTime frameDescription
Change in subjective levels of perceived knee pain over six weeksUpon initial recruitment to the study, and once per week for six weeks thereafterPain levels will be recorded by 100mm visual analog scale during weeks 1, 2, 3, 4, 5 and 6 of the study to monitor the efficacy of the intervention. Final change in pain will be compared between groups.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026